|
⚲
|
| Keyboard |
| Dudley Robert Michael
✚
|
|
|---|---|
| CIK # | 0001854161 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001854161] | |
| 4 | [0001854161] | |
| SC 13D | [0001854161] | |
| SC 13G | [0001854161] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Dudley Robert Michael | Transcode Therapeutics Inc | [2022-12-20] |
| Dudley Robert Michael | Transcode Therapeutics Inc | [2022-12-20] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Transcode Therapeutics Inc | |
| Dudley Robert Michael |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Transcode Therapeutics Inc RNAZ
Common Stock
|
2023-09-28 | Buy | 98,000 | $0.51 | 49,980 |
|
Transcode Therapeutics Inc RNAZ
Common Stock
|
2023-06-21 | Buy | 12,000 | $2.65 | 31,800 |
|
Transcode Therapeutics Inc RNAZ
Common Stock
|
2023-06-20 | Buy | 6,607 | $2.55 | 16,848 |
|
Transcode Therapeutics Inc RNAZ
Common Stock
|
2023-06-09 | Buy | 19,000 | $2.76 | 52,440 |
|
Transcode Therapeutics Inc RNAZ
Stock Option (right to buy) · derivative
|
2023-05-19 | Grant | 735,000 | $0.00 | |
|
Transcode Therapeutics Inc RNAZ
Stock Option (Right to Buy) · derivative
|
2022-12-12 | Grant | 135,000 | $0.00 | |
|
Transcode Therapeutics Inc RNAZ
Common Stock
|
2022-09-14 | Buy | 20,000 | $1.15 | 23,000 |
|
Transcode Therapeutics Inc RNAZ
Common Stock
|
2022-05-31 | Buy | 2,000 | $1.87 | 3,740 |
|
Transcode Therapeutics Inc RNAZ
Common Stock
|
2022-05-27 | Buy | 28,000 | $1.84 | 51,520 |
|
Transcode Therapeutics Inc RNAZ
Stock Option (Right to Buy) · derivative
|
2022-02-01 | Grant | 135,000 | $0.00 |